These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35675923)

  • 1. End-point definition and trial design to advance tuberculosis vaccine development.
    Garcia-Basteiro AL; White RG; Tait D; Schmidt AC; Rangaka MX; Quaife M; Nemes E; Mogg R; Hill PC; Harris RC; Hanekom WA; Frick M; Fiore-Gartland A; Evans T; Dagnew AF; Churchyard G; Cobelens F; Behr MA; Hatherill M
    Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35675923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development.
    Hu Z; Lu SH; Lowrie DB; Fan XY
    Front Immunol; 2022; 13():895020. PubMed ID: 35812383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine development against tuberculosis before and after Covid-19.
    Kaufmann SHE
    Front Immunol; 2023; 14():1273938. PubMed ID: 38035095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Latest advances in the development of tuberculosis vaccines in global clinical trials: a review].
    Zhou F; Zhang Y; Zhang D
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):201-206. PubMed ID: 38857967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing tuberculosis vaccine efficacy trials - lessons from recent studies.
    Ginsberg AM
    Expert Rev Vaccines; 2019 May; 18(5):423-432. PubMed ID: 30892969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative clinical trial designs to rationalize TB vaccine development.
    Ellis RD; Hatherill M; Tait D; Snowden M; Churchyard G; Hanekom W; Evans T; Ginsberg AM
    Tuberculosis (Edinb); 2015 May; 95(3):352-7. PubMed ID: 25802031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials of TB vaccines: harmonization and cooperation.
    Mahomed H; Fourie PB
    Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S21-4. PubMed ID: 22441155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in development of new tuberculosis vaccines.
    da Costa C; Onyebujoh P; Thiry G; Zumla A
    Curr Opin Pulm Med; 2023 May; 29(3):143-148. PubMed ID: 36866744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update on Tuberculosis Vaccines.
    Gopalaswamy R; Subbian S
    Methods Mol Biol; 2022; 2410():387-409. PubMed ID: 34914059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis Vaccine Development: Progress in Clinical Evaluation.
    Sable SB; Posey JE; Scriba TJ
    Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31666281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of tuberculosis vaccines in clinical trials: Current status.
    Méndez-Samperio P
    Scand J Immunol; 2018 Oct; 88(4):e12710. PubMed ID: 30175850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-Based Vaccines for Tuberculosis.
    Gong W; Pan C; Cheng P; Wang J; Zhao G; Wu X
    Front Immunol; 2022; 13():830497. PubMed ID: 35173740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NATCON 2022 Panel discussion: "TB vaccination - Going Forward".
    Banurekha VV; Padmapriyadarsini C; Bhargava S; Sachdeva K
    Indian J Tuberc; 2023 Jul; 70(3):366-369. PubMed ID: 37562914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis vaccines and prevention of infection.
    Hawn TR; Day TA; Scriba TJ; Hatherill M; Hanekom WA; Evans TG; Churchyard GJ; Kublin JG; Bekker LG; Self SG
    Microbiol Mol Biol Rev; 2014 Dec; 78(4):650-71. PubMed ID: 25428938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of new tuberculosis vaccine in children.
    Pang Y; Zhao A; Cohen C; Kang W; Lu J; Wang G; Zhao Y; Zheng S
    Hum Vaccin Immunother; 2016 Apr; 12(4):960-70. PubMed ID: 27002369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human biomarkers: can they help us to develop a new tuberculosis vaccine?
    Fletcher HA; Dockrell HM
    Future Microbiol; 2016 Jun; 11():781-7. PubMed ID: 27203133
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.